Potential of anticytokine therapies in central nervous system ischaemia

Bibliography

• KOCHANEK PM, HALLENBECK JM: Polymorphonuclearleukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke (1992) 23:1267–1379.
   Google Scholar
• BENVENISTE EN: Inflammatory cytokines within thecentral nervous system: sources, function, and mechanism of action. Am.J. Physiot (1992) 263:C1–C16.
   Web of Science ®Google Scholar
• FEUERSTEIN GZ, WANG X, YUE TL, BARONE FC: Inflam-matory cytokines and stroke: emerging new strategies for stroke therapeutics. In: Cerebrovascular Diseases: Nineteenth Princeton Stroke Conference. Moskowitz MA, Caplan LR (Eds.), Butterworth-Heinemann, Newton, MA (1995):75–91.
   Google Scholar
• • Good review of topic.
   Google Scholar
• MINAMI M, KURAISHI Y, YABUUCHI K, YAMAZAKI A, SATOH M: Induction of interleukin-1I3 mRNA in rat brain after transient forebrain ischemia. J. Neurochem. (1991) 58:390–392.
   Web of Science ®Google Scholar
• FASSBENDER K, ROSSOL S, KAMMER T et al.: Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J. Neurol. Sci. (1994) 122:135–139.
   PubMed Web of Science ®Google Scholar
• • Measures acute cytokine changes post-clinical stroke.
   Google Scholar
• TARKOWSKI E, ROSENGREN L, BLOMSTRAND C et al.: Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke (1995) 26:1393–1398.
   PubMed Web of Science ®Google Scholar
• • Demonstrates the relationship between CSF IL-6 and final infarct size.
   Google Scholar
• LUI T, YOUNG PR, MCDONNELL PC, WHITE RF, BARONEFC, FEUERRSTEIN GZ: Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosciences Lett. (1993) 164:125–128.
   PubMed Web of Science ®Google Scholar
• KIM JS, GAUTAM SC, CHOPP M et al.: Expression ofmonocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J. Neuroimmunol. (1995) 56:127-134a.
   Google Scholar
• KIM JS: Cytokines and adhesion molecules in stroke and related diseases. J. Neurol. Sci. (1996) 137:69-78. Brief overview of area.
   Google Scholar
• KOCHANEK PM, HALLENBECK JM: Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke (1992) 23:1367–1379.
   PubMed Web of Science ®Google Scholar
• CLARK WM, MADDEN KP, ROTHLEIN R, ZIVIN JA: Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J. Neurosurg. (1991) 75:623–627.
   PubMed Web of Science ®Google Scholar
• CLARK WM, MADDEN KP, ROTHLEIN R, ZIVIN JA: Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke (1991) 22:877–883.
   PubMed Web of Science ®Google Scholar
• SEI Y, VITKOVIC L, YOKOYAMA MM: Cytokines in thecentral nervous system: regulatory roles in neuronal function, cell death and repair. Neuroimmunomodula-tion (1995) 2:121–133.
   PubMed Web of Science ®Google Scholar
• DINARELLO CA, GELFAND JA, WOLFF SM: Anticytokinestrategies in the treatment of the systemic inflamma-tory response syndrome. JAMA (1993) 269:1829–1835.
   PubMed Web of Science ®Google Scholar
• CHUNG IL, BENVENISTE EN: Tumor necrosis factor production by astrocytes: Induction by lipopolysacha-ride, IFN-y, and IL-113. J. Immunol. (1990) 144:2999–3007.
   PubMed Web of Science ®Google Scholar
• ALOISI F, CAR F, BORSELLINO G et al.: Production ofhemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1I3 and tumor necrosis factor-a. J Immunol. (1992) 149:2358–2366.
   PubMed Web of Science ®Google Scholar
• SELMAJ K, FAROOQ M, NORTON WT, RAINE CS, BROSNAN CF: Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor. J. Immunol. (1990) 144:129–135.
   PubMed Web of Science ®Google Scholar
• FISHER C, SLOTMAN GJ, OPAL S: Interleukin-1 receptorantagonist reduces mortality in patients with sepsis syndrome. Presented at the fourth annual meeting of the American College of Chest Physicians. San Francisco, California, USA (1991).
   Google Scholar
• MCCARTHY PL, ABHYANKAR S, NEBEN S et al.: Inhibitionof interleukin-1 by interleukin-1 receptor antagonist prevents graft versus host disease. Blood (1991) 78: 1915-1918.
   Google Scholar
• OHLSSON K, BJORK P, BERGENFELDT M, HAGEMAN R,THOMPSON RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (1990) 348:550–552.
   PubMed Web of Science ®Google Scholar
• AIURA K, GELFAND JA, WAKABAYASHI G: Interleukin-1receptor antagonist blocks staphylococcal induced shock in rabbits. Cytokine (1991) 3:498.
   Google Scholar
• GERSHENWALD JE, FONG YM, FAHEY TJ III et al.: Interleukin-1 receptor blockade attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA (1990) 87:4966–4970.
   Google Scholar
• DI SANTO E, SIRONI M, POZZI P et al.: Interleukin-10inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-113 production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis. Neuroimmunomodulation (1995) 2:149–154.
   PubMed Web of Science ®Google Scholar
• BLACKWELL TS, CHRISTMAN JW: Sepsis and cytokines: current status. Br. J. Anaesth. (1996) 77:110-117. Good review of topic.
   Google Scholar
• FISHER CJ, DHAINAUT JF, OPAL SM et al Recombinant human interleukin- 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial. JAMA (1994) 271:1836.
   Google Scholar
• OPAL SM, FISHER CJ Jr, DHAINAUT JF et al.. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Crit. Care Med. (1997) 25(7):1115–1124.
   PubMed Web of Science ®Google Scholar
• LEBSACK ME, PAUL CC, BLOEDOW DC et al.: Subcutaneous IL-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum. (1991) 34:S67.
   Google Scholar
• THACKRAY S, WITTE K, CLARK A, CLELAND J: Clinical trials update: OPITME. Eur. J. Heart Failure (2000) 2:209–212.
   PubMed Web of Science ®Google Scholar
• ROTHWELL NJ, HOPKINS SJ: Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. (1995) 18:130–136.
   PubMed Web of Science ®Google Scholar
• • Good review.
   Google Scholar
• ROTHWELL N: Functions and mechanism of IL-1 in the brain. Trends Pharmacol. Sci. (1991) 12:430–435.
   PubMed Web of Science ®Google Scholar
• WANG XK, YUE T-L, BARONE FC, WHITE RF, GAGNON RC, FEUERSTEIN GZ: Concomitant cortical expression of TNFa and IL-113 m RNA following transient focal ischemia. Mol. Chem. Neuropathol. (1994) 23:103–114.
   PubMedGoogle Scholar
• YAMASAKI Y, MATSUURA N, SHOZUHARA H, ONODERA H, ITOYAMA Y, KOGURE K: Interleukin-1 as a pathoge-netic mediator of ischemic brain damage in rats. Stroke (1995) 26:676–681.
   PubMed Web of Science ®Google Scholar
• RELTON JK, ROTHWELL NJ: Interleukin-1 receptor antagonist inhibits ischemic and excitotoydc neuronal damage in the rat. Brain Res. Bull. (1992) 29:243–246
   PubMed Web of Science ®Google Scholar
• •• Initial report of IL-lra treatment effect.
   Google Scholar
• GARCIA JH, LIU KF, RELTON JK: Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. (1995) 147:1477–1486.
   PubMed Web of Science ®Google Scholar
• LODDICK SA, ROTHWELL NJ: Neuroprotective effects of human recombinant interleukin-1 receptor antago-nist in focal cerebral ischemia in the rat./ Cereb. Blood Flow Metab. (1996) 16(5):932–940.
   Google Scholar
• BETZ AL, YANG GY, AND DAVIDSON BL: Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. (1995) 15:547–551.
   PubMed Web of Science ®Google Scholar
• • Novel approach for delivery.
   Google Scholar
• RELTON J, MARTIN D, THOMPSON R, RUSSEL D: Peripheral administration of interleukin-1 receptor antago-nist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol. (1996) 138:206–213.
   PubMed Web of Science ®Google Scholar
• •• May have future clinical application.
   Google Scholar
• SHARIEF M, HENTGES R: Association between TNFa and disease progression in patients with multiple sclerosis. N. Engl. J. Med. (1991) 325:467–472.
   PubMed Web of Science ®Google Scholar
• LIU T, CLARK RK, MCDONNELL PC et al.: Tumor necrosis factor expression in ischemic neurons. Stroke (1994) 25:1481–1488.
   PubMed Web of Science ®Google Scholar
• WANG X, YUE T, BARONE F: Concomitant cortical expression of TNFa mRNA following transient focal ischemia. Mol. Chem. Neuropathol. (1994) 23:103–114.
   PubMedGoogle Scholar
• CHAO C, EHRLICH L, PETERSON P: IL-1 and TNFa synergistically mediate neurotoxicity. Brain Behav. Immun. (1995) 374:647–650.
   Google Scholar
• MEISTRELL M, COCKROFT KM, BOTCHKINA GI et al.: TNF mediates brain damage in stroke. Stroke (1997) 28:255.
   Google Scholar
• HALLENBECK JM: Cytokines, macrophages, and leukocytes in brain ischemia. In: Advances in Stroke Management: Proceeding Highlights. Sherman DG (Ed.) (1996) 5:5–10.
   Google Scholar
• LAVINE S, HOFMAN F, ZLOKOVIC B: Circulating antibody against TNFa protects rat brain from reperfu-sion injury. J. Cereb. Blood Flow Metab. (1998) 18:52–58.
   PubMed Web of Science ®Google Scholar
• BRUCE A, BOLING W, KINDY M et al.: Altered neuronaland microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. (1996) 2:788–794.
   PubMed Web of Science ®Google Scholar
• ZHAI QH, FUTRELL N, CHEN FJ: Calcium bound calmodulin is upregulated following TNFa inhibition with antisense oligonucleotide after middle cerebral artery occlusion (MCAO) in the rat. Stroke. (1997) 28:225.
   Google Scholar
• AKIRA S, TAGA T, KISHIMOTO T: Interleukin-6 in biology and medicine. Adv. Immunol. (1993) 54:1–78.
   PubMed Web of Science ®Google Scholar
• MATHIESEN T, ANDERSSON B, LOFTENUS A, VON HOLSTH: Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J. Neurosurg. (1993) 78:562–567.
   PubMed Web of Science ®Google Scholar
• MERRILL JE, STROM SR, ELLISON GW, MYERS LW: In vitro study of mediators of inflammation in multiple sclerosis. J. Clin. Immunol. (1989) 9:84–96.
   PubMed Web of Science ®Google Scholar
• HIROHATA S, MIYAMOTO T: Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. (1990) 33:644–649.
   PubMed Web of Science ®Google Scholar
• GIJBELS K, VANDAMME J, PROOST P, PUT W, CARTON H, BILLIAU A: Interleukin-6 production in the central nervous system during experimental autoirnmune encephalomyelitis. Fur. J. Immunol. (1990) 20:233–235.
   Web of Science ®Google Scholar
• WANG X, YUE T-L, YOUNG PR, BARONE FC, FEUERSTEIN GZ: Expression of interleukin-6, clos, and zif268 mRNA in rat ischemic cortex./ Cereb. Blood Flow Metab. (1995) 15:166–171.
   PubMed Web of Science ®Google Scholar
• • Initial report of IL-6 time course.
   Google Scholar
• TAUPIN V, TOULMOND S, SERRANO A, BENAVIDES J, ZAVALA F: Increase in IL-6, IL-1, and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral type (p site) benzodiazepine liquid. J. Neuroimmunol. (1993) 42:177–185.
   Google Scholar
• KUKIELKA GL, SMITH CW, MANNING AM, YOUKER KA,MICHAEL LH, ENTMAN ML: Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Stroke (1995) 92:1866–1875.
   Google Scholar
• CLARK W, LAUTEN J, COULL B, CHERRY N, WOODWARD W: ICAM-1 and IL-6 changes in the hippocampus following transient forebrain ischemia in the rat. Soc. Neurosci. (1993) 19:1664.
   Google Scholar
• CLARK W, RINKER L, LESSOV N, HAZEL K: Time course of IL-6 expression in experimental CNS ischemia. Neurol. Res. (1999) 21:287–292.
   PubMed Web of Science ®Google Scholar
• TOULMOND S, VIGE X, FAGE D, BENAVIDES J: Localinfusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci. Lett. (1992) 144:49–52.
   PubMed Web of Science ®Google Scholar
• CAMPBELL IL, ABRAHAM CR, MASLIAH E et al.: Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc. Natl. Acad. Sci. USA (1993) 90:10061–10065.
   PubMed Web of Science ®Google Scholar
• ROTHWELL NJ, RELTON JK: Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci. Biobehav. Rev. (1992)17:217–227.
   Web of Science ®Google Scholar
• SELMAJ KW, FAROOQ M, NORTON WT, RAINE CS, BROSNAN CF: Proliferation of astrocytes in vitro in response to cytokines. J. Immunol. (1990)144:129–135.
   PubMed Web of Science ®Google Scholar
• CLARK W, RINKER L, LESSOV N et al.: Lack of IL-6 expres-sion is not protective against focal CNS ischemia. Stroke (2000) 31: 1715-1720.
   Google Scholar
• •• Initial report of IL-6 modulation in CNS ischaemia.
   Google Scholar
• BEAMER NB, COULL BM, CLARK WM, HAZEL JS, SILBERGER JR: Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann. Neurol. (1995) 37:800–804.
   PubMed Web of Science ®Google Scholar
• •• Initial report of IL-lra levels post stroke.
   Google Scholar
• CLARK WM, HAZEL JS, BEAMER N, WYNN M, COULL B: The initial acute phase response predicts long term stroke recovery. Stroke (1996) 27:186.
   Google Scholar
• ELNEIHOUM AM, FALKE P, AXELSSON L, LUNDBERG E, LINDGARDE F, OHLSSON K: Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke (1996) 27:1734–1738.
   PubMed Web of Science ®Google Scholar
• CLARK WM, COULL BM, BEAMER NB: Need for treatment of elevated plasma fibrinogen levels in cerebrovas-cular disease. Heart Dis. Stroke (1993) 2:503–506.
   PubMedGoogle Scholar
• COULL BM, BEAMER N, CLARK WM: Elevated plasma interleukin-6 in acute stroke. Stroke (1993) 24:183.
   Google Scholar
• YOUKER KA, SMITH CW, ANDERSON DC et al.: Neutro-phil adherence to isolated adult cardiac myocytes: induction by cardiac lymph collected during ischemia and reperfusion. J. Clin. Invest. (1992) 89:602–609.
   PubMed Web of Science ®Google Scholar
• ZHANG R, CHOPP M, JIANG N et al.: Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but no permanent middle cerebral artery occlusion in the wistar rat. Stroke (1995) 26:1438–1443.
   PubMed Web of Science ®Google Scholar
• ENLIMOMAB ACUTE STROKE TRIAL INVESTIGATORS: Enlimomab acute stroke trial; final results. Neurology (2001) (In press).
   Google Scholar
• FROHMAN EM, FROHMAN TC, DUSTIN ML et al.: The induction of intracellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-y, tumor necrosis factor a, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J. Neuroimmunol. (1989) 23:117–124.
   PubMed Web of Science ®Google Scholar
• POBER JS, GIMBRONE MA, LAPIERRE LA et al.: Overlap-ping patterns of activation of human endothelial cells by interlukin-1, tumor necrosis factor, and immune interferon. J. Immunol. (1986) 137:1893–1896.
   PubMed Web of Science ®Google Scholar
• CHUNG IY, BENVENISTE EN: TNF-a production by astrokcytes: induction by lipopolysaccharide, interferon-gamma and interleukin-1. J. Immunol. (1990) 144:2999–3007.
   PubMed Web of Science ®Google Scholar
• LIEBERMAN AP, PITHA PM, SHIN HS, SHIN ML: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA. (1989) 867:6348–6352.
   Web of Science ®Google Scholar
• CLARK WM, LAUTEN JD, BEAMER NB, COULL BM: Cytokine and superoxide production in clinical stroke. J. Stroke Cerebrovasc. Dis. (1995) 5:166–171.
   Google Scholar
• CLARK WM, LAUTEN JD, LESSOV N, WOODWARD W, COULL BM: Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol. Chem. Neuropathol. (1995) 26:213–230.
   PubMedGoogle Scholar
• NAWASHIRO H, TASAKI K, RUETZLER CA, HALLENBECK JM. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb. Blood Flow Metab. (1997) 17(5):483–490.
   PubMed Web of Science ®Google Scholar
• SPERA P, ELLISON J, FEURSTEIN G, BARONE F: IL-10reduces rat brain injury following focal stroke. Neurosci. Lett. (1998) 251:189–192.
   PubMed Web of Science ®Google Scholar
• KUMAR S,. MCDONELL P, GUM R, HAND A, LEE J, YOUNG P: Novel homologues of p38 MAP kinase. Biochem. Biophys. Res. Comm. (1997) 235:533–538.
   PubMed Web of Science ®Google Scholar
• BARONE F, FEUERSTEIN G, WHITE R, IRVING E PARSONS A: Selective inhibition of p38 mitogen activated kinase reduces brain injury and neurological deficits in the rat. J. Cereb. Blood Flow Metab. (1999) 19:613.
   Google Scholar